EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial–Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer

Madhumathy G Nair iD, Apoorva D Mavatkar, Chandrakala M Naidu, Snijesh V P iD, Anupama C E, Savitha Rajarajan, Sarthak Sahoo, Gayathri Mohan, Vishnu Sunil Jaikumar, Rakesh S Ramesh, Srinath B S, Mohit Kumar Jolly iD und 2 weitere

Cells · 2024

DOI: 10.3390/cells13100821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Madhumathy G Nair und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Medicine, St. John's Research Institute, St. John's Medical College, Bangalore 560034, Karnataka, India. Hauptthemen laut MEDLINE: MicroRNAs, Epithelial-Mesenchymal Transition, Breast Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research, Department of Health Research, Ministry of Health & Family Welfare, and ICMR India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic alterations that lead to differential expression of microRNAs (miRNAs/miR) are known to regulate tumour cell states, epithelial–mesenchymal transition (EMT) and the progression to metastasis in breast cancer. This study explores the key contribution of miRNA-18a in mediating a hybrid E/M cell state that is pivotal to the malignant transformation and tumour progression in the aggressive ER-negative subtype of breast cancer. The expression status and associated effects of miR-18a were evaluated in patient-derived breast tumour samples in combination with gene expression data from public datasets, and further validated in in vitro and in vivo breast cancer model systems. The clinical relevance of the study findings was corroborated against human breast tumour specimens (n = 446 patients). The down-regulated expression of miR-18a observed in ER-negative tumours was found to drive the enrichment of hybrid epithelial/mesenchymal (E/M) cells with luminal attributes, enhanced traits of migration, stemness, drug-resistance and immunosuppression. Further analysis of the miR-18a targets highlighted possible hypoxia-inducible factor 1-alpha (HIF-1α)-mediated signalling in these tumours. This is a foremost report that validates the dual role of miR-18a in breast cancer that is subtype-specific based on hormone receptor expression. The study also features a novel association of low miR-18a levels and subsequent enrichment of hybrid E/M cells, increased migration and stemness in a subgroup of ER-negative tumours that may be attributed to HIF-1α mediated signalling. The results highlight the possibility of stratifying the ER-negative disease into clinically relevant groups by analysing miRNA signatures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsEpithelial-Mesenchymal TransitionBreast NeoplasmsGene Expression Regulation, NeoplasticHumansFemaleDisease ProgressionReceptors, EstrogenCell Line, TumorHypoxia-Inducible Factor 1, alpha SubunitPhenotypeAnimalsMiceCell Movement

Stichwörter der Autor:innen

ER-negative breast cancerchemoresistanceepithelial–mesenchymal transitionhybrid E/M phenotypemicroRNA-18astem-like cells

Substanzen

MicroRNAsMIRN18A microRNA, humanReceptors, EstrogenHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Division of Molecular Medicine, St. John's Research Institute, St. John's Medical College, Bangalore 560034, Karnataka, India.
  • Department of Bioengineering, Indian Institute of Science (Bangalore), Bengaluru 560012, Karnataka, India.
  • Cancer Research, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram 695014, Kerala, India.
  • Animal Research Facility, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram 695014, Kerala, India.
  • Department of Surgical Oncology, St. John's Medical College and Hospital, Bangalore 560034, Karnataka, India.
  • Department of Surgical Oncology, Sri Shankara Cancer Hospital and Research Centre, Bangalore 560004, Karnataka, India.

ORCID-Profile: Madhumathy G Nair, Snijesh V P, Mohit Kumar Jolly, Tessy Thomas Maliekal, Jyothi S Prabhu

Förderung

  • Indian Council of Medical Research
  • Department of Health Research, Ministry of Health & Family Welfare, and ICMR India

Zitieren

APA

Nair, M. G., Mavatkar, A. D., Naidu, C. M., V P, S., C E, A., Rajarajan, S., Sahoo, S., Mohan, G., Jaikumar, V. S., Ramesh, R. S., B S, S., Jolly, M. K., Maliekal, T. T., & Prabhu, J. S. (2024). Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial–Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer. Cells. https://doi.org/10.3390/cells13100821

Vancouver

Nair MG, Mavatkar AD, Naidu CM, V P S, C E A, Rajarajan S, et al. Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial–Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer. Cells. 2024. doi:10.3390/cells13100821

BibTeX
@article{Nair2024,
  author = {Nair, Madhumathy G and Mavatkar, Apoorva D and Naidu, Chandrakala M and V P, Snijesh and C E, Anupama and Rajarajan, Savitha and Sahoo, Sarthak and Mohan, Gayathri and Jaikumar, Vishnu Sunil and Ramesh, Rakesh S and B S, Srinath and Jolly, Mohit Kumar and Maliekal, Tessy Thomas and Prabhu, Jyothi S},
  title = {Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial–Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13100821}
}
Kostenlos starten →